Minimum effective dose and duration to reverse neutropenia in non-cancer patients with advanced HIV disease

AIDS. 1996 Aug;10(9):1050-1. doi: 10.1097/00002030-199610090-00023.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Child
  • Female
  • Granulocyte Colony-Stimulating Factor / therapeutic use*
  • HIV Infections / complications*
  • Humans
  • Male
  • Middle Aged
  • Neutropenia / drug therapy*
  • Neutropenia / etiology

Substances

  • Granulocyte Colony-Stimulating Factor